Inventor · disambiguated record
Ying-Duo Gao
Also filed as: GAO YING · GAO YING-DUO
31 granted patents·13 pending applications·277 citations·filing 1997–2023
95Inventor score
Files withMERCK SHARP & DOHME9MERCK & CO INC7MERCK SHARP & DOHME LLC7CHILDRENS MEDICAL CENTER4MIDDLE TENNESSEE STATE UNIV4
Top patents by PatentIndex Score
44 records- 0196US6313298B1Spiro-indolines as Y5 receptor antagonistsMERCK & CO INC·Filed 2000·Granted Nov 6, 2001·79 cites·21 claims
- 0292US6191160B1Spiro-indolines as Y5 receptor antagonistsMERCK & CO INC·Filed 1999·Granted Feb 20, 2001·79 cites·15 claims
- 0386US10093683B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Oct 9, 2018·4 cites·13 claims
- 0485US6028103ATriaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 1997·Granted Feb 22, 2000·36 cites·42 claims
- 0583US9868727B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jan 16, 2018·3 cites·16 claims
- 0680US6638942B1Spiro-indolines as Y5 receptor antagonistsMERCK & CO INC·Filed 2002·Granted Oct 28, 2003·10 cites·13 claims
- 0779US10123995B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Nov 13, 2018·2 cites·14 claims
- 0878US7482336B2Aminocyclohexanes as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK & CO INC·Filed 2005·Granted Jan 27, 2009·3 cites·13 claims
- 0976US10011585B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Jul 3, 2018·2 cites·12 claims
- 1075US6331564B1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseION PHARMACEUTICALS INC·Filed 1998·Granted Dec 18, 2001·43 cites·13 claims
- 1174US10081617B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Sep 25, 2018·2 cites·11 claims
- 1274US6495559B2NPY Y5 receptor antagonistsMERCK & CO INC·Filed 2001·Granted Dec 17, 2002·5 cites·16 claims
- 1372US9481682B2Substituted benzamides and substituted pyridinecarboxamides as Btk inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted Nov 1, 2016·2 cites·23 claims
- 1470US7956061B2Bicyclic pyrimidines as dipeptidyl peptidase-IV inhibitors for the treatment or prevention of diabetesMERCK SHARP & DOHME·Filed 2006·Granted Jun 7, 2011·1 cites·8 claims
- 1565US12497403B2Factor XIa inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Granted Dec 16, 2025·0 cites·19 claims
- 1664US6800658B2Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment of prevention of diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 2002·Granted Oct 5, 2004·3 cites·16 claims
- 1763US11007169B2Cis-gnetin H and trans-gnetin H as therapeutic agentsMIDDLE TENNESSEE STATE UNIV·Filed 2019·Granted May 18, 2021·0 cites·10 claims
- 1857US2025099478A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2023·Application pending·0 cites
- 1956US2004063942A1Spiro-indolines as Y5 receptor antagonistsMERCK & CO INC·Filed 2003·Application pending·0 cites
- 2055US12492187B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Dec 9, 2025·0 cites·11 claims
- 2155US12428397B2Factor XI activation inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Sep 30, 2025·0 cites·13 claims
- 2254US10993920B22-dodecyl-6-methoxycyclohexa-2,5-diene-1,4-dione as a cancer therapeuticMIDDLE TENNESSEE STATE UNIV·Filed 2015·Granted May 4, 2021·0 cites·9 claims
- 2353US12459927B2Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Granted Nov 4, 2025·0 cites·16 claims
- 2452US2024208994A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2022·Application pending·0 cites
- 2552US2024025917A1Plasma kallikrein inhibitorsMERCK SHARP & DOHME LLC·Filed 2021·Application pending·0 cites
- 2652US2002119953A1Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseFiled 2001·Application pending·0 cites
- 2750US7342038B2Substituted diphenyl indanone, indane and indole compounds and analogues thereof useful for the treatment or prevention of diseases characterized by abnormal cell proliferationHARVARD COLLEGE·Filed 2004·Granted Mar 11, 2008·0 cites·15 claims
- 2847US6864383B2Ophthalmic compositions for treating ocular hypertensionMERCK & CO INC·Filed 2002·Granted Mar 8, 2005·0 cites·32 claims
- 2947US2009156629A1Indenoisoquinoline-releasable polymer conjugatesENZON PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 3047US2003191111A1Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationCHILDRENS MEDICAL CENTER·Filed 2003·Application pending·0 cites
- 3145US2002128256A1Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferationFiled 2001·Application pending·0 cites
- 3243US2018221329A1Cis- and trans-suffruticosol d as therapeutic agentsMIDDLE TENNESSEE STATE UNIV·Filed 2016·Application pending·0 cites
- 3343US2008097108A1Ophthalmic Compositions for Treating Ocular HypertensionGAO YING-DUO·Filed 2005·Application pending·0 cites
- 3443US2007293558A1Ophthalmic Compositions for Treating Ocular HypertensionGAO YING-DUO·Filed 2005·Application pending·0 cites
- 3542US7531573B2Use of triaryl methane compounds for inhibiting unwanted cellular proliferation associated with inflammatory diseaseCHILDRENS MEDICAL CENTER·Filed 2003·Granted May 12, 2009·0 cites·11 claims
- 3641US8153626B2Substituted diazepine sulfonamides as bombesin receptor subtype-3 modulatorsBAKER ROBERT K·Filed 2007·Granted Apr 10, 2012·0 cites·20 claims
- 3740US7659408B2Pyrazole carboxamides as inhibitors of 11-β-hydroxysteroid dehydrogenase-1MERCK SHARP & DHOME CORP·Filed 2004·Granted Feb 9, 2010·0 cites·1 claims
- 3839US9975874B2Factor XIa inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted May 22, 2018·0 cites·16 claims
- 3938US10214512B2Factor XIA inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Feb 26, 2019·0 cites·14 claims
- 4036US2017326098A1Cis-gnetin h and trans-gnetin h as therapeutic agentsMIDDLE TENNESSEE STATE UNIV·Filed 2015·Application pending·0 cites
- 4134US6992079B2Substituted 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationNUCHEM PHARMACEUTICALS INC·Filed 2001·Granted Jan 31, 2006·0 cites·22 claims
- 4234US6534497B1Substitute 11-phenyl-dibenzazepine compounds useful for the treatment or prevention of diseases characterized by abnormal cell proliferationNUCHEM PHARMACEUTICALS INC·Filed 1998·Granted Mar 18, 2003·3 cites·29 claims
- 4333US12397158B2System for locally activating the human eye and the brain in order to train visual performance, in particular in order to activate the visual cortex and reorganized neural networks in the human brain in order to strengthen residual visionSAVIR GmbH·Filed 2020·Granted Aug 26, 2025·0 cites·23 claims
- 4427US2003134842A1Methods for the treatment or prevention of inflammatory diseases characterized by abnormal cell proliferationFiled 1998·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Ying-Duo Gao files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →